Improving Swallowing Assessment in Cancer Patients with DIGEST™
This study is testing different ways to help hospitals and clinics use a tool called DIGEST™ (Dynamic Imaging Grade of Swallowing Toxicity) to better assess swallowing difficulties (dysphagia) in cancer patients. Researchers want to see if a "DIGEST Training Program" or "DIGEST Training + Practice Facilitation" helps clinics adopt this tool in their routine care. The main goal is to see how many clinics start using DIGEST™ in their records for Modified Barium Swallow (MBS) studies in oncology patients over about one year. To join, your hospital or clinic must be part of the Veteran's Affairs, University of Wisconsin, or Ohio State University systems, perform at least 10 MBS procedures on cancer patients monthly, and archive those imaging files. The study's current status is unclear, and it plans to enroll 85 participants.
- Study design
- This is an interventional study that compares different implementation strategies for DIGEST™. It is a randomized implementation trial, but the phase is not specified.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint is measured through study completion, which is an average of one year.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Dissemination and Implementation of DIGEST™ as an Evidence-based Measurement Tool for Dysphagia: A Randomized Implementation Trial
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Kate Hutcheson, PHD · PRINCIPAL_INVESTIGATOR · M.D. Anderson Cancer Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Adoption of DIGEST in routine clinical documentation for oncology MBS studiesThrough study completion; an average of 1 year